Jane Street
ONC

Jane Street’s BeOne Medicines Ltd ONC Stock Holding History

Jane Street’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.51M Buy
15,200
+3,500
+30% +$1.13M ﹤0.01% 3667
2025
Q4 		$3.55M Sell
11,700
-10,600
-48% -$3.47M ﹤0.01% 3763
2025
Q3 		$7.6M Buy
22,300
+2,900
+15% +$881K ﹤0.01% 2796
2025
Q2 		$4.7M Buy
19,400
+12,200
+169% +$2.99M ﹤0.01% 3086
2025
Q1 		$1.96M Sell
7,200
-1,300
-15% -$304K ﹤0.01% 4382
2024
Q4 		$1.57M Buy
8,500
+1,800
+27% +$368K ﹤0.01% 4550
2024
Q3 		$1.5M Sell
6,700
-17,100
-72% -$3.08M ﹤0.01% 5044
2024
Q2 		$3.4M Buy
23,800
+12,000
+102% +$1.85M ﹤0.01% 3598
2024
Q1 		$1.85M Buy
11,800
+2,800
+31% +$451K ﹤0.01% 4277
2023
Q4 		$1.62M Buy
9,000
+100
+1% +$18.1K ﹤0.01% 4697
2023
Q3 		$1.6M Sell
8,900
-200
-2% -$39.6K ﹤0.01% 4422
2023
Q2 		$1.62M Buy
9,100
+2,100
+30% +$484K ﹤0.01% 4478
2023
Q1 		$1.51M Sell
7,000
-5,600
-44% -$1.34M ﹤0.01% 4296
2022
Q4 		$2.77M Sell
12,600
-6,000
-32% -$1.1M ﹤0.01% 3348
2022
Q3 		$2.51M Buy
18,600
+11,800
+174% +$2.03M ﹤0.01% 3791
2022
Q2 		$1.1M Sell
6,800
-27,700
-80% -$4.33M ﹤0.01% 5315
2022
Q1 		$6.51M Buy
34,500
+27,800
+415% +$5.91M ﹤0.01% 2603
2021
Q4 		$1.81M Sell
6,700
-2,500
-27% -$844K ﹤0.01% 4670
2021
Q3 		$3.34M Buy
9,200
+8,300
+922% +$2.71M ﹤0.01% 3458
2021
Q2 		$309K Sell
900
-9,500
-91% -$3.15M ﹤0.01% 8094
2021
Q1 		$3.62M Sell
10,400
-800
-7% -$265K ﹤0.01% 2908
2020
Q4 		$2.89M Buy
11,200
+7,900
+239% +$2.18M ﹤0.01% 2868
2020
Q3 		$945K Sell
3,300
-2,700
-45% -$635K ﹤0.01% 4185
2020
Q2 		$1.13M Buy
+6,000
New +$977K ﹤0.01% 3884
2020
Q1 		– Sell
-1,500
Closed -$249K – 6121
2019
Q4 		$249K Buy
+1,500
New +$249K ﹤0.01% 4506
2019
Q1 		– Sell
-2,200
Closed -$309K – 5761
2018
Q4 		$309K Buy
+2,200
New +$292K ﹤0.01% 4031
2018
Q3 		– Sell
-4,500
Closed -$692K – 5825
2018
Q2 		$692K Sell
4,500
-31,000
-87% -$5.53M ﹤0.01% 3221
2018
Q1 		$5.96M Buy
+35,500
New +$4.81M 0.02% 848

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jane Street's ONC Position: Q1 2026 in Review

Jane Street opened a new position in BeOne Medicines Ltd (ONC) in Q1 2026: 75,953 shares worth $22.6M. The stake represents ﹤0.01% of the portfolio and ranks #1679 among its holdings. This is a return to the name: Jane Street previously reported a position in ONC as recently as Q3 2025.

Jane Street first reported a position in ONC in Q3 2017 and has held it in 25 quarters since. The position peaked at $24.4M in Q1 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

  • Jane Street held 75,953 shares of BeOne Medicines Ltd worth $22.6M as of Q1 2026.
  • BeOne Medicines Ltd was a new Jane Street position in Q1 2026.
  • BeOne Medicines Ltd made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #1679 holding.
  • Jane Street first reported a position in BeOne Medicines Ltd in Q3 2017 and has held it in 25 quarters since.
  • Jane Street's BeOne Medicines Ltd position peaked at $24.4M in Q1 2025.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.